The serpin proteinase inhibitor 9 is an endogenous inhibitor of interleukin 1beta-converting enzyme (caspase-1) activity in human vascular smooth muscle cells
about
Induction of serine protease inhibitor 9 by Mycobacterium tuberculosis inhibits apoptosis and promotes survival of infected macrophagesDiscriminating between the activities of human neutrophil elastase and proteinase 3 using serpin-derived fluorogenic substratesEctopic expression of the serine protease inhibitor PI9 modulates death receptor-mediated apoptosisIntracellular serine protease inhibitor SERPINB4 inhibits granzyme M-induced cell deathRegulation of inflammasome signalingOf inflammasomes and pathogens--sensing of microbes by the inflammasomeSerine proteinase inhibitor 9 can be recognized by cytotoxic T lymphocytes of epithelial cancer patientsInflammasomes: caspase-1-activating platforms with critical roles in host defenseAryl hydrocarbon receptor (AhR) regulates silica-induced inflammation but not fibrosisThe inflammasome NLRs in immunity, inflammation, and associated diseasesCharacterisation of PAUSE-1, a powerful silencer in the human plasminogen activator inhibitor type 2 gene promoterThe antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines.Granzymes in age-related cardiovascular and pulmonary diseases.Role of caspase 1 in murine antibacterial host defenses and lethal endotoxemia.Intracellular versus extracellular granzyme B in immunity and disease: challenging the dogma.Enhanced expression of CD44 variants in human atheroma and abdominal aortic aneurysm: possible role for a feedback loop in endothelial cells.Early hyperlipidemia promotes endothelial activation via a caspase-1-sirtuin 1 pathwayalpha-1 antitrypsin inhibits caspase-3 activity, preventing lung endothelial cell apoptosis.The potential role of DNA methylation in abdominal aortic aneurysms.T(H)2 predominant immune responses prevail in human abdominal aortic aneurysm.CD8+ T cell cytotoxicity mediates pathology in the skin by inflammasome activation and IL-1β production.Flightless-I regulates proinflammatory caspases by selectively modulating intracellular localization and caspase activity.The role of Granzyme B in atheromatous diseases.Serine protease inhibitor 6 plays a critical role in protecting murine granzyme B-producing regulatory T cells.LRRFIP2 negatively regulates NLRP3 inflammasome activation in macrophages by promoting Flightless-I-mediated caspase-1 inhibition.A novel antiapoptotic role for alpha1-antitrypsin in the prevention of pulmonary emphysema.The role of serpins in vertebrate immunity.Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells.Serpins in T cell immunity.Dendritic cell subtypes as primary targets of vaccines: the emerging role and cross-talk of pattern recognition receptors.Sustained inflammasome activity in macrophages impairs wound healing in type 2 diabetic humans and mice.Regulation of inflammasome activity.Serine protease inhibitors and cytotoxic T lymphocytes.Inflammasome inhibition as a pathogenic stealth mechanism.Research progress on the NLRP3 inflammasome and its role in the central nervous system.Modulators of inflammation use nuclear factor-kappa B and activator protein-1 sites to induce the caspase-1 and granzyme B inhibitor, proteinase inhibitor 9.The hidden side of SERPINB1/Leukocyte Elastase Inhibitor.Serpins prevent granzyme-induced death in a species-specific manner.Interplay between estrogen response element sequence and ligands controls in vivo binding of estrogen receptor to regulated genes.Expression of interleukin (IL)-18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for atherogenesis.
P2860
Q24297607-4F646E9C-DBB9-4C44-A115-6C361020594AQ24301375-1D118713-5918-44C5-9AAB-F5870E801E11Q24304892-10D75FE8-58CC-4A3E-825A-C310BDC7001BQ24324387-1A14AD28-A196-49CD-AA6C-6BD83FC100D0Q26996605-86DFF98C-EECA-4188-AE72-95C0C5547B39Q27000785-7043C0EA-E933-4D21-82B9-E5949C609A98Q28202640-C0CA0710-A255-445E-9BC9-378EAB78F21DQ28389138-0CA00438-3275-4FEE-BF04-8C0432070D76Q28397728-10B0611F-9755-4E3F-99C8-35AE397C69B7Q29616025-163238C3-43CF-41BB-A581-CC547FF0B197Q33948414-C9CFC85D-EE84-46DD-B8BA-9D5A166B9570Q34015778-4A98DE4B-F445-4726-86A2-6D4331BC3A5BQ34097453-F8E414C8-09BB-486A-8F90-4DC5B01217ACQ34262238-F916C9DD-DA46-4CF2-98C3-9889C714F7B5Q35004399-B9B6C758-62FF-4268-A38A-48B067066B00Q35103442-4E8FBA9B-F312-448E-B46F-70010BD3B376Q35224401-B46E1538-CC4B-4DCC-9FC6-B651458C53C4Q35607245-49252B5F-B853-40C3-B382-89F81AB78973Q35723702-21BCEB24-10F5-4E84-B7D5-7F019F0302B3Q35747563-0ABEF4D6-3F0D-412A-B45A-828C1679FA89Q36278760-9DDB58BD-5E08-4D28-AF02-18FEDE309410Q36562930-B9B8BFE1-53CF-4459-B9EF-E9820BAC2CDDQ36814760-64C24291-8A91-4DE9-AE64-96D292EDCAAFQ37112525-C58088B2-3392-4C7D-9667-1DCEBA8E40C8Q37121805-8009017F-6A46-4871-A89E-AC0DA9E6B147Q37144496-F608B2DC-6C94-4C5E-B193-F95D12776C68Q37170955-3E6AE38D-59A1-4FBB-B493-C710356B5669Q37221453-2E25F249-1D49-4015-93D9-849B854BE794Q37222018-0A0E19E8-E29C-496E-A881-3241BAA776CBQ37309247-6007322B-30EB-4157-BA3A-6060096B7742Q37597048-FB23E6FC-4F7D-42E9-8987-D1F25F5B7F08Q37750913-99756361-5512-4E32-9D09-F87A94B98375Q37763997-9EB41168-1AC8-439A-9402-1105B58E1F60Q37773683-16B9A2C8-7683-4897-92E7-EC28A40AF81AQ38091387-C671191D-5ECA-4315-B8F1-9D2557FE839EQ38363673-C41F73F3-1B01-483A-B45D-44EFA57DDEC1Q38898379-C236EBD5-02B4-4CAC-945D-6E15F9AABD34Q40331824-1503C6D7-64A3-41E8-9AAD-D24F68959200Q40616435-F7B3586D-0CE9-431C-ABE9-0609EF1A5F28Q42944624-B1972F77-1FE1-4982-ABD1-686352B7ABA1
P2860
The serpin proteinase inhibitor 9 is an endogenous inhibitor of interleukin 1beta-converting enzyme (caspase-1) activity in human vascular smooth muscle cells
description
2000 nî lūn-bûn
@nan
2000 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
The serpin proteinase inhibito ...... n vascular smooth muscle cells
@ast
The serpin proteinase inhibito ...... n vascular smooth muscle cells
@en
The serpin proteinase inhibito ...... n vascular smooth muscle cells
@en-gb
The serpin proteinase inhibito ...... n vascular smooth muscle cells
@nl
type
label
The serpin proteinase inhibito ...... n vascular smooth muscle cells
@ast
The serpin proteinase inhibito ...... n vascular smooth muscle cells
@en
The serpin proteinase inhibito ...... n vascular smooth muscle cells
@en-gb
The serpin proteinase inhibito ...... n vascular smooth muscle cells
@nl
prefLabel
The serpin proteinase inhibito ...... n vascular smooth muscle cells
@ast
The serpin proteinase inhibito ...... n vascular smooth muscle cells
@en
The serpin proteinase inhibito ...... n vascular smooth muscle cells
@en-gb
The serpin proteinase inhibito ...... n vascular smooth muscle cells
@nl
P2093
P2860
P921
P356
P1476
The serpin proteinase inhibito ...... n vascular smooth muscle cells
@en
P2093
P2860
P304
P356
10.1084/JEM.191.9.1535
P407
P577
2000-05-01T00:00:00Z